STIM
Neuronetics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Neuronetics, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
No other changes.
No other changes.
Annual filing, covered
10-K parsed · Mar 17 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 17 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
+47.00%
vs ±24.4% implied · ×1.92
shaded = implied · ▲▼ = realized
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Neuronetics, Inc.'s 5 closest co-movers, none share that code.
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; of Neuronetics, Inc.'s 5 closest co-movers, none share that code.
No thesis.
Neuronetics, Inc.
2.25
+0.19 · +9.22%
post 2.31 +2.67%
Tall tick = annual report · Source: EDGAR
Largest filed tie
—
News
| Manager | Value | % base | |
|---|---|---|---|
| Madryn | $24.1M | 49.68% | +0.35% |
| UBS | $3.0M | 6.11% | −20.61% |
| Wexford Capital | $2.6M | 5.37% | +185.70% |
| FourWorld | $2.3M | 4.67% | +17.11% |
| Lane Generational | $2.1M | 4.38% | −7.96% |
| Manager | Value | % base | |
|---|---|---|---|
| Madryn | $24.1M | 49.68% | +0.35% |
| UBS | $3.0M | 6.11% | −20.61% |
| Wexford Capital | $2.6M | 5.37% | +185.70% |
| FourWorld | $2.3M | 4.67% | +17.11% |
| Lane Generational | $2.1M | 4.38% | −7.96% |
Expected move
No implied move.